HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H J Lee Selected Research

human pegylated granulocyte colony-stimulating factor

1/2017A randomized, multi-center, open-label, phase III study of once-per-cycle DA-3031, a pegylated G-CSF, in comparison with daily filgrastim in patients receiving TAC chemotherapy for breast cancer.
10/2013A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H J Lee Research Topics

Disease

25Neoplasms (Cancer)
01/2022 - 05/2000
23Shock
09/2021 - 06/2000
12Breast Neoplasms (Breast Cancer)
11/2022 - 03/2008
8Infections
06/2016 - 01/2000
5Insulin Resistance
11/2022 - 08/2002
5Inflammation (Inflammations)
11/2022 - 09/2000
5Neoplasm Metastasis (Metastasis)
11/2017 - 05/2001
5Pain (Aches)
09/2010 - 02/2000
4Hemorrhage
08/2017 - 03/2001
4Stomach Neoplasms (Stomach Cancer)
12/2016 - 05/2001
4Lung Neoplasms (Lung Cancer)
12/2014 - 06/2001
4Hypertriglyceridemia
10/2013 - 04/2001
4Alzheimer Disease (Alzheimer's Disease)
05/2007 - 05/2001
4Hyperalgesia
07/2005 - 03/2001
3Type 2 Diabetes Mellitus (MODY)
06/2017 - 01/2001
3Obesity
12/2016 - 01/2013
3Arthritis (Polyarthritis)
01/2016 - 07/2008
3Stroke (Strokes)
11/2009 - 01/2001
3Atherosclerosis
08/2008 - 03/2001
3Body Weight (Weight, Body)
11/2007 - 04/2000
3Carcinoma (Carcinomatosis)
09/2006 - 10/2000
3Atopic Dermatitis (Atopic Eczema)
12/2001 - 05/2000
3Prostatic Neoplasms (Prostate Cancer)
09/2001 - 06/2000
3Edema (Dropsy)
03/2001 - 02/2000
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 01/2015
2Head and Neck Neoplasms (Head and Neck Cancer)
01/2018 - 05/2000
2Hypoxia (Hypoxemia)
11/2017 - 03/2016
2Hepatocellular Carcinoma (Hepatoma)
08/2017 - 04/2000
2Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2017 - 10/2013
2Wounds and Injuries (Trauma)
04/2017 - 05/2015
2Neutropenia
01/2017 - 10/2013
2Disease Progression
10/2016 - 05/2000
2Hypersensitivity (Allergy)
09/2016 - 11/2006
2Colorectal Neoplasms (Colorectal Cancer)
05/2013 - 09/2009
2Diabetes Mellitus
04/2013 - 04/2013
2Tuberculosis (Tuberculoses)
12/2012 - 11/2005
2Medulloblastoma
11/2012 - 11/2011

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
11/2017 - 09/2000
5Glucose (Dextrose)FDA LinkGeneric
11/2022 - 08/2002
5Pharmaceutical PreparationsIBA
05/2018 - 09/2005
5Messenger RNA (mRNA)IBA
04/2016 - 05/2000
5Insulin (Novolin)FDA Link
04/2013 - 08/2002
4LipidsIBA
11/2022 - 09/2001
4Biomarkers (Surrogate Marker)IBA
01/2022 - 03/2012
4EnzymesIBA
03/2016 - 12/2009
4CytokinesIBA
12/2012 - 03/2001
3DiamondIBA
09/2021 - 03/2016
3TantalumIBA
12/2019 - 10/2017
3PlasticsIBA
06/2018 - 11/2014
3VaccinesIBA
04/2016 - 12/2004
3Small Interfering RNA (siRNA)IBA
03/2016 - 07/2010
3Irinotecan (Camptosar)FDA LinkGeneric
12/2013 - 11/2011
3SteroidsIBA
04/2013 - 08/2006
3ProdrugsIBA
11/2012 - 11/2011
3Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2009 - 02/2000
3Amyloid beta-PeptidesIBA
05/2007 - 05/2001
3AntigensIBA
12/2001 - 01/2000
2PalmitatesIBA
11/2022 - 06/2011
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022 - 09/2003
2ErbB Receptors (EGF Receptor)IBA
10/2021 - 01/2015
2CarbonIBA
09/2021 - 03/2016
2RNA-Binding Proteins (RNA-Binding Protein)IBA
05/2019 - 01/2017
2Estrogen Receptor alphaIBA
05/2019 - 01/2017
2Polystyrenes (Polystyrene)IBA
03/2019 - 07/2018
2Dopamine (Intropin)FDA LinkGeneric
01/2019 - 01/2001
2BismuthIBA
11/2018 - 08/2015
2Drinking WaterIBA
10/2018 - 04/2016
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2018 - 12/2003
2Silicon Dioxide (Silica)FDA LinkGeneric
11/2017 - 09/2015
2MetalsIBA
01/2017 - 09/2016
2human pegylated granulocyte colony-stimulating factorIBA
01/2017 - 10/2013
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2017 - 03/2001
2Docetaxel (Taxotere)FDA Link
01/2017 - 11/2003
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2017 - 03/2001
2Filgrastim (Neupogen)FDA Link
01/2017 - 10/2013
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2017 - 10/2013
2AllergensIBA
09/2016 - 03/2001
2GemcitabineFDA Link
01/2015 - 11/2009
2AluminumIBA
11/2014 - 02/2013
2Fluorouracil (Carac)FDA LinkGeneric
05/2013 - 06/2012
2ORALIT (ORS)IBA
01/2013 - 09/2009
2Interleukin-2 (IL2)IBA
12/2012 - 03/2001
2Interleukin-10 (Interleukin 10)IBA
12/2012 - 05/2000
2Cytosine DeaminaseIBA
11/2012 - 06/2012
2BerylliumIBA
04/2012 - 03/2009

Therapy/Procedure

16Therapeutics
01/2018 - 03/2001
10Drug Therapy (Chemotherapy)
10/2021 - 10/2000
10Lasers (Laser)
12/2019 - 08/2010
7Radiotherapy
04/2012 - 06/2000
3Aftercare (After-Treatment)
01/2019 - 04/2005
3Catheters
05/2018 - 10/2010
2Adjuvant Chemotherapy
12/2019 - 12/2001
2Length of Stay
01/2018 - 12/2016
2Free Tissue Flaps
01/2018 - 04/2003
2Combination Drug Therapy (Combination Chemotherapy)
01/2017 - 11/2003
2Gastrectomy
12/2016 - 02/2012
2Hematopoietic Stem Cell Transplantation
06/2016 - 08/2006
2Transplantation
03/2016 - 05/2015
2Injections
10/2013 - 06/2001
2Liver Transplantation
04/2012 - 04/2012